{
  "trial_id": "NCT00061373",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Diagnosis of acute ischemic stroke with planned start of intravenous tPA.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Disabling neurological deficit attributable to acute ischemic stroke.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "NIHSS less than or equal to 21 for left hemisphere strokes, NIHSS less than or equal to 16 for others.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Age 18-85 years, inclusive.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Body weight greater than 50 kg.",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Current participation in another study with an investigational drug or device within, prior participation in the present study, or planned participation in another therapeutic trial, prior to the final (day 30) assessment in this trial.",
      "label": "not_met",
      "evidence": "unknown"
    },
    {
      "criterion": "Symptoms suggestive of subarachnoid hemorrhage, even if CT or MRI scan is negative for hemorrhage.",
      "label": "not_met",
      "evidence": "quote"
    }
  ],
  "notes": "62-year-old African-American man with left upper and lower extremity weakness, associated with dark visual spot in right eye, right facial numbness, facial drop and slurred speech. He denied dyspnea, headache, palpitations, chest pain, fever, dizziness, bowel or urinary incontinence, loss of consciousness.",
  "_meta": {
    "topic_id": "47",
    "trial_id": "NCT00061373",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}